AMPH logo

AMPH Cash and cash equivalents

annual cash & cash equivalents:

$151.61M+$7.31M(+5.07%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AMPH annual cash & cash equivalents is $151.61 million, with the most recent change of +$7.31 million (+5.07%) on December 31, 2024.
  • During the last 3 years, AMPH annual cash & cash equivalents has risen by +$25.26 million (+19.99%).
  • AMPH annual cash & cash equivalents is now -2.88% below its all-time high of $156.10 million, reached on December 31, 2022.

Performance

AMPH Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHbalance sheet metrics

quarterly cash & cash equivalents:

$182.78M+$31.17M(+20.56%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AMPH quarterly cash & cash equivalents is $182.78 million, with the most recent change of +$31.17 million (+20.56%) on March 31, 2025.
  • Over the past year, AMPH quarterly cash & cash equivalents has dropped by -$18.37 million (-9.13%).
  • AMPH quarterly cash & cash equivalents is now -31.49% below its all-time high of $266.78 million, reached on September 30, 2023.

Performance

AMPH quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

AMPH Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.1%-9.1%
3 y3 years+20.0%+5.9%
5 y5 years+105.8%+233.3%

AMPH Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.9%+20.0%-31.5%+26.7%
5 y5-year-2.9%+105.8%-31.5%+109.2%
alltimeall time-2.9%+201.9%-31.5%+280.2%

AMPH Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$182.78M(+20.6%)
Dec 2024
$151.61M(+5.1%)
$151.61M(-21.1%)
Sep 2024
-
$192.12M(+1.3%)
Jun 2024
-
$189.62M(-5.7%)
Mar 2024
-
$201.15M(+39.4%)
Dec 2023
$144.30M(-7.6%)
$144.30M(-45.9%)
Sep 2023
-
$266.78M(+79.5%)
Jun 2023
-
$148.59M(-15.9%)
Mar 2023
-
$176.62M(+13.1%)
Dec 2022
$156.10M(+23.5%)
$156.10M(-0.7%)
Sep 2022
-
$157.24M(-5.4%)
Jun 2022
-
$166.16M(-3.7%)
Mar 2022
-
$172.63M(+36.6%)
Dec 2021
$126.35M(+36.4%)
$126.35M(+18.5%)
Sep 2021
-
$106.61M(+1.1%)
Jun 2021
-
$105.43M(+3.8%)
Mar 2021
-
$101.60M(+9.7%)
Dec 2020
$92.64M(+25.7%)
$92.64M(+5.4%)
Sep 2020
-
$87.91M(+0.6%)
Jun 2020
-
$87.39M(+59.3%)
Mar 2020
-
$54.84M(-25.6%)
Dec 2019
$73.69M
$73.69M(-13.9%)
Sep 2019
-
$85.61M(-28.9%)
DateAnnualQuarterly
Jun 2019
-
$120.37M(+52.2%)
Mar 2019
-
$79.10M(-8.4%)
Dec 2018
$86.34M(+31.6%)
$86.34M(+25.6%)
Sep 2018
-
$68.73M(+43.0%)
Jun 2018
-
$48.07M(-11.9%)
Mar 2018
-
$54.55M(-16.8%)
Dec 2017
$65.59M(-9.3%)
$65.59M(-2.0%)
Sep 2017
-
$66.92M(-18.9%)
Jun 2017
-
$82.54M(+7.5%)
Mar 2017
-
$76.77M(+6.1%)
Dec 2016
$72.35M(+9.5%)
$72.35M(+8.6%)
Sep 2016
-
$66.60M(-0.1%)
Jun 2016
-
$66.66M(+5.3%)
Mar 2016
-
$63.33M(-4.1%)
Dec 2015
$66.07M(-2.6%)
$66.07M(-6.5%)
Sep 2015
-
$70.68M(-5.1%)
Jun 2015
-
$74.46M(+8.6%)
Mar 2015
-
$68.59M(+1.1%)
Dec 2014
$67.83M(+26.6%)
$67.83M(-6.9%)
Sep 2014
-
$72.88M(+13.7%)
Jun 2014
-
$64.08M(+22.9%)
Mar 2014
-
$52.13M(-2.7%)
Dec 2013
$53.59M(+6.7%)
$53.59M
Dec 2012
$50.21M
-

FAQ

  • What is Amphastar Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

What is Amphastar Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of AMPH is $151.61M

What is the all time high annual cash & cash equivalents for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual cash & cash equivalents is $156.10M

What is Amphastar Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, AMPH annual cash & cash equivalents has changed by +$7.31M (+5.07%)

What is Amphastar Pharmaceuticals quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of AMPH is $182.78M

What is the all time high quarterly cash & cash equivalents for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly cash & cash equivalents is $266.78M

What is Amphastar Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

Over the past year, AMPH quarterly cash & cash equivalents has changed by -$18.37M (-9.13%)
On this page